LHC — Q2 2022 Earnings Presentation
29 slides from LHC's earnings presentation, Aug 3, 2022
Slide 1: Supplemental Financial Information Second Quarter Ended June 30, 2022
SUPPLEMENTAL FINANCIAL INFORMATION Second Quarter Ended June 30, 2022 August 3, 2022 Exhibit 99.2
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company, or the timing or anticipated benefits of pending acquisitio
Slide 3: Table of Contents
TABLE OF CONTENTS BUSINESS OVERVIEW 4-10 LHC Group Overview Commentary on Q2 2022 Home Health Labor Cost per Visit Industry-Leading Quality and Patient Satisfaction Legislative and Regulatory Update 3 2022 CONSOLIDATED RESULTS 11-15 2022 Adjusted Consolidated Results Adjusted Consolidated Results –
Slide 4: Business Overview
BUSINESS OVERVIEW
Slide 5: LHC Group Overview
Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC GROUP OVERVIEW LEGEND: 543 home health locations 169 hospice locations 135 home & community based services locations 12 long term acute care hospital locations 94 other service locations 435 leading ho
Slide 6: Commentary on Q2 2022
Adjusted net income attributable to LHC Group’s common stockholders was $29.8 million, or $0.98 adjusted earnings per diluted share in Q2 2022. Adjusted EBITDA was $53.0 million in Q2 2022. The labor market continues to remain challenging driven by higher wages, sign-on and retention bonuses, increa
Slide 7: Labor cost assumptions and cost per visit commentary
Labor cost assumption for 2022, inclusive of bonuses, was an increase of 3% to 5% over 2021. This assumed that labor cost would remain flat with Q4 2021 which was 7.7% above Q2 2021. Home Health salaries and wages cost per visit, inclusive of sign-on and retention bonuses, increased 8.1% in Q2 2022
Slide 8: Home Health Labor Cost per Visit
HOME HEALTH LABOR COST PER VISIT 8
Slide 9: Industry-Leading Quality and Patient Satisfaction
INDUSTRY-LEADING QUALITY AND PATIENT SATISFACTION 100% of LHC Group home health and hospice agencies are Joint Commission accredited or are in the accreditation process within 12 to 18 months after acquisition. Approximately 15% of all Medicare certified home health agencies nationwide are Joint Com
Slide 10: Legislative and Regulatory Update
Choose Home Care Act (HR5514 and S2562) Gained 12 new co-sponsors in recent months for a total of 42 in the House and 18 in the Senate. This important legislation is a candidate for inclusion in a legislative vehicle this Congress pending a score on budgetary impact by the Congressional Budget Offic
Slide 11: 2022 Consolidated Results
2022 CONSOLIDATED RESULTS
Slide 12: 2022 Adjusted Consolidated Results
2022 ADJUSTED CONSOLIDATED RESULTS 12
Slide 13: Adjusted Consolidated Results – 2022 vs 2021
ADJUSTED CONSOLIDATED RESULTS – 2022 VS 2021 13
Slide 14: Adjustments to Net Income
ADJUSTMENTS TO NET INCOME *See footnotes on page 15 14
Slide 15: Adjustments to Net Income Continued
ADJUSTMENTS TO NET INCOME CONTINUED Expenses and other costs associated with recently announced or completed acquisitions, de novos and the pending acquisition by UnitedHealth Group. ($9.2 million pre-tax in the three months ended June 30, 2022 and $13.3 million pre-tax in the six months ended June
Slide 16: Segment Results
SEGMENT RESULTS
Slide 17: Three Months Ended June 30, 2022 Adjusted Segment Results
THREE MONTHS ENDED JUNE 30, 2022 ADJUSTED SEGMENT RESULTS 17
Slide 18: Six Months Ended June 30, 2022 Adjusted Segment Results
SIX MONTHS ENDED JUNE 30, 2022 ADJUSTED SEGMENT RESULTS 18
Slide 19: Home Health Segment Adjusted Segment Results – 2022 vs 2021
HOME HEALTH SEGMENT ADJUSTED SEGMENT RESULTS – 2022 VS 2021 For the three months ended June 30, 2022, Revenue decreased by $3.8 million or 0.9% as compared to Q2 2021. The decrease in revenue is due to a 1.4% decline in average daily census and a return of 1% of sequestration, partially offset by a
Slide 20: Home Health Segment Adjusted Same Store Segment Results
HOME HEALTH SEGMENT ADJUSTED SAME STORE SEGMENT RESULTS – 2022 VS 2021 20 Same store excludes any Home Health provider that was acquired between July 1, 2021 and June 30, 2022. Despite the cost headwinds faced in the quarter, same store EBITDA as a percent of revenue improved sequentially by 30 basi
Slide 21: Hospice Segment Adjusted Segment Results – 2022 vs 2021
For the three months ended June 30, 2022, revenue increased $38.8 million. The increase in revenue is due to approximately $36.2 million of inorganic revenue from recent acquisitions and approximately $2.6 million from same store growth offset by 1% of sequestration return. For the three months ende
Slide 22: Hospice Segment Adjusted Same Store Results – 2022 vs 2021
22 HOSPICE SEGMENT ADJUSTED SAME STORE RESULTS – 2022 VS 2021 Same store excludes any Hospice provider that was acquired between July 1, 2021 and June 30, 2022. For the three months ended June 30, 2022, Same Store EBITDA increased $1.4 million, or 150 basis points as a percentage of revenue, as comp
Slide 23: Home and Community Based Services Segment Adjusted Results
For the three months ended June 30, 2022, revenue decreased $3.7 million compared to Q2 2021 and EBITDA decreased $1.7 million, or 320 basis points as a percentage of revenue, as compared to Q2 2021. The decrease in revenue and EBITDA is due to a 9.8% decline in billable hours owing to ongoing staff
Slide 24: Facility-Based Services Segment Adjusted Results
For the three months ended June 30, 2022, revenue decreased by $0.3 million compared to Q2 2021. The decrease in revenue was caused by a 15.3% reduction in LTACH revenue, largely offset by higher Therapy revenue acquired as part of the HCA/Brookdale transaction. The LTACH revenue decline is attribut
Slide 25: Health Care Innovations Segment Adjusted Segment Results
25 HEALTH CARE INNOVATIONS SEGMENT ADJUSTED SEGMENT RESULTS – 2022 VS 2021
Slide 26: Appendix
APPENDIX
Slide 27: Non-GAAP Reconciliations
NON-GAAP RECONCILIATIONS (AMOUNTS IN THOUSANDS, UNAUDITED) *Footnotes are on page 28 27
Slide 28: Non-GAAP Reconciliations: Adjusted EBITDA
NON-GAAP RECONCILIATIONS (AMOUNTS IN THOUSANDS, UNAUDITED) Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) 28 Expenses and other costs associated with recently announced or completed acquisitions, de novos and the pending acquisition by UnitedHealth Group. (
Slide 29: LHC Group – It's all about helping people
LH Cc GROUP It’s all about helping people.